Soleno Therapeutics Inc
Biotechnology · Healthcare
Board Member
2026-05-18–present
Matthew C. Abernethy
Board Member
Soleno Therapeutics Inc
Soleno Therapeutics Inc
Equibles does not estimate personal net worth.
About Matthew C. Abernethy
Matthew C. Abernethy is recorded as Board Member at Soleno Therapeutics Inc since May 18, 2026. Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Matthew C. Abernethy was appointed Treasurer and Vice President, effective May 18, 2026. Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Matthew C. Abernethy was appointed director of the Company, effective May 18, 2026. Soleno Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector.
“Following the Effective Time, the officers of the Company are as follows: Darin M. Lippoldt (President and Secretary) and Matthew C. Abernethy (Treasurer and Vice President).”
“Matthew C. Abernethy and Darin M. Lippoldt became the directors of the Company, in each case, as of the Effective Time.”
Affiliation history
-
Soleno Therapeutics Inc
Board Member
SEC 8-K
Current2026-05-18–present
-
Soleno Therapeutics Inc
SEC 8-K
Current2026-05-18–present